101 related articles for article (PubMed ID: 4868647)
1. Plaque-forming cells in the spleens of rabbits immunized with viable BCG bacilli or oil cell wall vaccine from Mycobacterium bovis.
Larson C; Baker MB; Smith D
Am Rev Respir Dis; 1968 Apr; 97(4):715-8. PubMed ID: 4868647
[No Abstract] [Full Text] [Related]
2. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.
Taniyama T; Azuma I; Yamamura Y
Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834
[TBL] [Abstract][Full Text] [Related]
3. Immunization of rabbits with viable BCG and nonliving cell wall vaccines.
Larson CL; Baker RE; Baker MB
Am Rev Respir Dis; 1968 Dec; 98(6):944-53. PubMed ID: 4881317
[No Abstract] [Full Text] [Related]
4. Effects of oil-treated mycobacterial cell walls on the organs of mice.
Barclay WR; Anacker R; Brehmer W; Ribi E
J Bacteriol; 1967 Nov; 94(5):1736-45. PubMed ID: 4965197
[TBL] [Abstract][Full Text] [Related]
5. Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG).
Minden P; Sharpton TR; McClatchy JK
J Immunol; 1976 May; 116(5):1407-14. PubMed ID: 58033
[TBL] [Abstract][Full Text] [Related]
6. Immunization of mice by combinations of inactive fractions of Mycobacterium bovis strain BCG.
Anacker RL; Bickel WD; Brehmer W; Niwa M; Ribi E; Tarmina DF
Proc Soc Exp Biol Med; 1969 Mar; 130(3):723-30. PubMed ID: 4975293
[No Abstract] [Full Text] [Related]
7. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
8. Effect of oil-attached BCG cell-wall skeleton and thymectomy on the incidence of lung cancer and amyloidosis induced by chemical carcinogens in rabbits.
Hirao F; Nishikawa H; Yasaki S; Ogura T; Azuma I; Taniyama T; Yoshimoto T; Kishimoto S; Yamamura Y
Gan; 1978 Aug; 69(4):453-9. PubMed ID: 101411
[TBL] [Abstract][Full Text] [Related]
9. Effect of oil-attached BCG cell-wall skeleton on the induction of pleural fibrosarcomas in mice.
Yoshimoto T; Azuma I; Sakatani M; Nishikawa H; Ogura T
Gan; 1976 Jun; 67(3):441-5. PubMed ID: 793922
[TBL] [Abstract][Full Text] [Related]
10. Skin reactions in rabbits sensitized with typical and atypical mycobacteria and tested with homologous and heterologous protoplasm.
Larson C; Ribi E; Baker MB; List R; Baker R; Wicht W
Am Rev Respir Dis; 1966 Dec; 94(6):923-32. PubMed ID: 5332111
[No Abstract] [Full Text] [Related]
11. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
Taniyama T; Azuma I; Aladin AA; Yamamura Y
Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of humoral immune responses. I. Potentiating influence of purified protein derivative on the invitro immune response of spleen cells sensitized to Mycobacterium bovis and Mycobacterium avium.
Muscoplat CC; Setcavage TM; Thoen CO; Kim YB
Int Arch Allergy Appl Immunol; 1976; 52(1-4):266-72. PubMed ID: 797671
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant and antitumor activities of Nocardia cell-wall skeletons.
Azuma I; Taniyama T; Yamawaki M; Sugimura K; Yamamura Y
Gan; 1976 Oct; 67(5):733-6. PubMed ID: 797626
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of cell-wall skeletons and peptidoglycolipids of mycobacteria and related microörganisms in mice and rabbits.
Azuma I; Taniyama T; Hirao F; Yamamura Y
Gan; 1974 Dec; 65(6):493-505. PubMed ID: 4219357
[No Abstract] [Full Text] [Related]
15. Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c--a member of the esat-6 gene family.
Hogarth PJ; Logan KE; Vordermeier HM; Singh M; Hewinson RG; Chambers MA
Vaccine; 2005 Apr; 23(20):2557-64. PubMed ID: 15780437
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
[TBL] [Abstract][Full Text] [Related]
17. Activation of guinea pig macrophages by cell walls of Mycobacterium bovis, strain BCG.
Kelly MT
Cell Immunol; 1976 Oct; 26(2):254-63. PubMed ID: 824056
[No Abstract] [Full Text] [Related]
18. Successful treatment of the patients with malignant pleural effusion with BCG cell-wall skeleton.
Yamamura Y; Ogura T; Yoshimoto T; Nishikawa H; Sakatani M
Gan; 1976 Oct; 67(5):669-77. PubMed ID: 797625
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
